REVB · Revelation Biosciences, Inc.

Substantial doubt about the company's ability to continue as a going concern.

“The Company does not anticipate that its current cash and cash equivalents balance will be sufficient to sustain operations within one year after the date that the Company's unaudited condensed financial statements for June 30, 2026 were issued, which raises substantial doubt about its ability to continue as a going concern.”